SCHEMBL4384337

SCHEMBL4384337

COC(=O)OC(C)OC(=O)C(CCCC(=O)O)C(C)OC(=O)OC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.37
ALDH1A1 P00352 1/20 0.33
FOLH1 Q04609 5/20 0.32
PLA2G10 O15496 1/20 0.31
ENPEP Q07075 2/20 0.31
GSTK1 Q9Y2Q3 2/20 0.31
ADRA1A P35348 1/20 0.31
GABRP O00591 2/20 0.31
GABRD O14764 2/20 0.31
GABRA1 P14867 2/20 0.31
GABRB1 P18505 2/20 0.31
GABRG2 P18507 2/20 0.31
GABRB3 P28472 2/20 0.31
GABRA5 P31644 2/20 0.31
GABRA3 P34903 2/20 0.31
GABRA2 P47869 2/20 0.31
GABRB2 P47870 2/20 0.31
GABRA4 P48169 2/20 0.31
GABRE P78334 2/20 0.31
GABRA6 Q16445 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4394675 0.95 TSHR (0.36) TSHRALDH1A1ENPEPGSTK1ADRA1A
SCHEMBL4388239 0.94 ALDH1A1 (0.38) TSHRALDH1A1GSTK1ADRA1ABHMT
SCHEMBL4384284 0.94 ALDH1A1 (0.38) TSHRALDH1A1GSTK1ADRA1ABHMT
SCHEMBL4388242 0.94 ALDH1A1 (0.38) TSHRALDH1A1GSTK1ADRA1ABHMT
SCHEMBL4386107 0.94 ALDH1A1 (0.38) TSHRALDH1A1GSTK1ADRA1ABHMT
SCHEMBL4395469 0.94 ALDH1A1 (0.38) TSHRALDH1A1GSTK1ADRA1ABHMT
SCHEMBL4394097 0.88 ALDH1A1 (0.33) TSHRALDH1A1PLA2G10GABRPGABRD
SCHEMBL4395402 0.84 FFAR4 (0.36) TSHRALDH1A1
SCHEMBL4389902 0.83 ENPEP (0.32) TSHRENPEPGSTK1GABRPGABRD
SCHEMBL4388748 0.83 FFAR4 (0.39) TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7629383-B2 Double esters DRUG DISCOVERY LABORATORY AS (NO) 2009-12-08 US disclosed
US-20050203181-A1 Double esters DRUG DISCOVERY LABORATORY AS (NO) 2005-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050203181-A1 Double esters ACACA, CES1, ACACB TSHR 1933/4885ALDH1A1 296/4885FOLH1 1201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.